黏菌素与其他抗菌药物联合对耐黏菌素鲍曼不动杆菌临床分离株的协同作用。
Synergistic activities of colistin combined with other antimicrobial agents against colistin-resistant Acinetobacter baumannii clinical isolates.
机构信息
Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
出版信息
PLoS One. 2022 Jul 13;17(7):e0270908. doi: 10.1371/journal.pone.0270908. eCollection 2022.
Abstract
Emerging resistance to colistin in Acinetobacter baumannii clinical strains is concerning because of the limited therapeutic choices for these important clinical pathogens. We studied the in vitro activities of different colistin-based antimicrobial agent combinations against colistin-resistant Acinetobacter baumannii. Fourteen clinical isolates of colistin-resistant Acinetobacter baumannii were obtained between 2015 and 2016. To identify colistin-based combinations with synergistic activities, multiple two antimicrobial combinations based on 8 commercially available drugs were evaluated by the checkerboard method. The most effective colistin-based combinations were vancomycin, aztreonam, ceftazidime and imipenem which showed synergistic activities against all examined strains. Colistin-rifampin showed synergy against four strains. Colistin-tigecycline and colistin-amikacin mostly showed indifferent results. By using the checkerboard tests, we were able to find the most promising colistin-based combinations that may provide more therapeutic options against colistin-resistant Acinetobacter baumannii.
摘要
耐多粘菌素鲍曼不动杆菌临床株的耐药性不断出现令人担忧，因为这些重要的临床病原体的治疗选择有限。我们研究了不同多粘菌素为基础的抗菌药物组合对多粘菌素耐药鲍曼不动杆菌的体外活性。在 2015 年至 2016 年期间获得了 14 株多粘菌素耐药鲍曼不动杆菌的临床分离株。为了确定具有协同作用的多粘菌素组合，通过棋盘法评估了基于 8 种市售药物的多种两种抗菌药物组合。对所有检测菌株均显示协同作用的最有效的多粘菌素组合是万古霉素、氨曲南、头孢他啶和亚胺培南。多粘菌素-利福平对四种菌株显示协同作用。多粘菌素-替加环素和多粘菌素-阿米卡星主要表现为无关结果。通过棋盘试验，我们能够找到最有前途的多粘菌素组合，这可能为治疗多粘菌素耐药鲍曼不动杆菌提供更多的治疗选择。
相似文献
1
Synergistic activities of colistin combined with other antimicrobial agents against colistin-resistant Acinetobacter baumannii clinical isolates.黏菌素与其他抗菌药物联合对耐黏菌素鲍曼不动杆菌临床分离株的协同作用。
PLoS One. 2022 Jul 13;17(7):e0270908. doi: 10.1371/journal.pone.0270908. eCollection 2022.
2
In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.抗菌药物联合对耐黏菌素鲍曼不动杆菌临床分离株的体外协同活性
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6774-6779. doi: 10.1128/AAC.00839-16. Print 2016 Nov.
3
In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates.抗碳青霉烯类鲍曼不动杆菌血分离株的体外时间杀菌研究，包括多粘菌素或替加环素耐药分离株。
J Med Microbiol. 2012 Mar;61(Pt 3):353-360. doi: 10.1099/jmm.0.036939-0. Epub 2011 Oct 20.
4
In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.黏菌素、替加环素和多尼培南抗生素组合对广泛耐药和多重耐药鲍曼不动杆菌的体外相互作用
Ann Lab Med. 2016 Mar;36(2):124-30. doi: 10.3343/alm.2016.36.2.124.
5
In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates.黏菌素与利福平及碳青霉烯类药物对耐黏菌素鲍曼不动杆菌临床分离株的体外抗菌协同作用
Diagn Microbiol Infect Dis. 2016 Oct;86(2):184-9. doi: 10.1016/j.diagmicrobio.2016.07.017. Epub 2016 Jul 19.
6
In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii.利福平、黏菌素、舒巴坦和替加环素单独及联合使用对广泛耐药鲍曼不动杆菌的体外活性。
J Antibiot (Tokyo). 2014 Sep;67(9):677-80. doi: 10.1038/ja.2014.99. Epub 2014 Aug 6.
7
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.非传统抗菌药物单独或联合使用对从重症监护病房分离出的多重耐药铜绿假单胞菌和鲍曼不动杆菌菌株的体外活性。
Int J Antimicrob Agents. 2006 Mar;27(3):224-8. doi: 10.1016/j.ijantimicag.2005.10.012. Epub 2006 Feb 7.
8
In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.黏菌素与替加环素或β-内酰胺类抗生素/β-内酰胺酶抑制剂组合对耐碳青霉烯类鲍曼不动杆菌的体外协同活性。
J Int Med Res. 2013 Dec;41(6):1830-7. doi: 10.1177/0300060513496172.
9
[Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].[多黏菌素-氨苄西林/舒巴坦联合用药对耐亚胺培南鲍曼不动杆菌菌株的疗效评估]
Mikrobiyol Bul. 2013 Jan;47(1):147-51. doi: 10.5578/mb.4523.
10
Evaluation of the Colistin-Carbapenem Combination in Clinical Isolates of Using the Checkerboard, Etest, and Time-Kill Curve Techniques.运用棋盘法、Etest法和时间杀菌曲线技术评估黏菌素-碳青霉烯类联合用药对[具体临床分离株]的效果
Front Cell Infect Microbiol. 2017 May 24;7:209. doi: 10.3389/fcimb.2017.00209. eCollection 2017.
引用本文的文献
1
Synergistic action between peptide-neomycin conjugates and polymyxin B against multidrug-resistant gram-negative pathogens.肽-新霉素偶联物与多粘菌素B对多重耐药革兰氏阴性病原体的协同作用。
Front Microbiol. 2025 Aug 7;16:1605813. doi: 10.3389/fmicb.2025.1605813. eCollection 2025.
2
Colistin Resistance Mechanism and Management Strategies of Colistin-Resistant Infections.黏菌素耐药机制及耐黏菌素感染的管理策略
Pathogens. 2024 Nov 28;13(12):1049. doi: 10.3390/pathogens13121049.
3
Effect of colistin-tigecycline combination on colistin-resistant and carbapenem-resistant and .黏菌素-替加环素联合用药对耐黏菌素和耐碳青霉烯类的影响及……（原文最后不完整）
Microbiol Spectr. 2025 Feb 4;13(2):e0202124. doi: 10.1128/spectrum.02021-24. Epub 2024 Dec 19.
4
Insertion Sequences within Oxacillinases Genes as Molecular Determinants of Resistance to Carbapenems-A Pilot Study.作为对碳青霉烯类耐药分子决定因素的氧青霉烷酶基因内插入序列——一项初步研究
Microorganisms. 2024 Oct 12;12(10):2057. doi: 10.3390/microorganisms12102057.
5
Alteration in the Morphological and Transcriptomic Profiles of after Exposure to Colistin.暴露于黏菌素后[具体对象]的形态学和转录组学特征改变。 （注：原文中“of”后面缺少具体内容）
Microorganisms. 2024 Aug 11;12(8):1644. doi: 10.3390/microorganisms12081644.
6
Combinations of Antibiotics Effective against Extensively- and Pandrug-Resistant Patient Isolates.对广泛耐药和全耐药患者分离株有效的抗生素组合
Microorganisms. 2024 Jul 2;12(7):1353. doi: 10.3390/microorganisms12071353.
7
Genomic Insights into and In Vitro Evaluation of Antimicrobial Combination Therapies for Carbapenem-Resistant .对碳青霉烯类耐药菌的抗菌联合治疗进行基因组分析和体外评估。
Medicina (Kaunas). 2024 Jul 2;60(7):1086. doi: 10.3390/medicina60071086.
8
A Review on Colistin Resistance: An Antibiotic of Last Resort.关于黏菌素耐药性的综述：一种最后的抗生素
Microorganisms. 2024 Apr 11;12(4):772. doi: 10.3390/microorganisms12040772.
9
PmrAB, the two-component system of , controls the phosphoethanolamine modification of lipooligosaccharide in response to metal ions.PmrAB 是 的双组份系统，可响应金属离子控制脂寡糖的磷酸乙醇胺修饰。
J Bacteriol. 2024 May 23;206(5):e0043523. doi: 10.1128/jb.00435-23. Epub 2024 Apr 25.
10
Synthesis, Stereochemical Resolution, and Analogue Synthesis of Variabiline, an Aporphine Alkaloid That Sensitizes and to Colistin.合成、立体化学拆分及阿朴啡类生物碱变葫芦巴碱类似物的合成，该类似物可增强多黏菌素与靶标的亲和力。
ACS Infect Dis. 2024 Apr 12;10(4):1339-1350. doi: 10.1021/acsinfecdis.4c00026. Epub 2024 Mar 16.
本文引用的文献
1
Can Drug Repurposing be Effective Against Carbapenem-Resistant Acinetobacter baumannii?药物再利用能否有效对抗碳青霉烯类耐药鲍曼不动杆菌？
Curr Microbiol. 2021 Dec 14;79(1):13. doi: 10.1007/s00284-021-02693-5.
2
Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant .泛耐药菌抗菌联合治疗方案的系统评价
Antibiotics (Basel). 2021 Nov 3;10(11):1344. doi: 10.3390/antibiotics10111344.
3
Overview of Changes to the Clinical and Laboratory Standards Institute M100, 31st Edition.临床和实验室标准协会 M100，31 版更改概述。
J Clin Microbiol. 2021 Nov 18;59(12):e0021321. doi: 10.1128/JCM.00213-21. Epub 2021 Sep 22.
4
Insights into : A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen.深入剖析：一种威胁性医院病原体的微生物学、毒力和耐药特性综述
Antibiotics (Basel). 2020 Mar 12;9(3):119. doi: 10.3390/antibiotics9030119.
5
Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.解析广泛耐药鲍曼不动杆菌临床分离株中多粘菌素耐药机制。
mBio. 2019 Jul 16;10(4):e01083-19. doi: 10.1128/mBio.01083-19.
6
Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa.评价头孢他啶-阿维巴坦与美罗培南、阿米卡星、氨曲南、黏菌素或磷霉素联合使用对经过充分特征鉴定的多药耐药肺炎克雷伯菌和铜绿假单胞菌的协同作用。
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.00779-19. Print 2019 Aug.
7
Managing Acinetobacter baumannii infections.鲍曼不动杆菌感染的管理。
Curr Opin Infect Dis. 2019 Feb;32(1):69-76. doi: 10.1097/QCO.0000000000000518.
8
Risk factors of colistin safety according to administration routes: Intravenous and aerosolized colistin.根据给药途径的不同，粘菌素安全性的危险因素：静脉内和雾化粘菌素。
PLoS One. 2018 Nov 21;13(11):e0207588. doi: 10.1371/journal.pone.0207588. eCollection 2018.
9
Synergistic Effect of Colistin and Rifampin Against Multidrug Resistant : A Systematic Review and Meta-Analysis.黏菌素与利福平对多重耐药菌的协同作用：一项系统评价与荟萃分析
Open Microbiol J. 2017 Apr 28;11:63-71. doi: 10.2174/1874285801711010063. eCollection 2017.
10
In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.抗菌药物联合对耐黏菌素鲍曼不动杆菌临床分离株的体外协同活性
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6774-6779. doi: 10.1128/AAC.00839-16. Print 2016 Nov.
Zotero 插件